isoindigotin has been researched along with sulforaphane in 1 studies
Studies (isoindigotin) | Trials (isoindigotin) | Recent Studies (post-2010) (isoindigotin) | Studies (sulforaphane) | Trials (sulforaphane) | Recent Studies (post-2010) (sulforaphane) |
---|---|---|---|---|---|
26 | 0 | 18 | 1,754 | 65 | 1,317 |
Protein | Taxonomy | isoindigotin (IC50) | sulforaphane (IC50) |
---|---|---|---|
Epidermal growth factor receptor | Homo sapiens (human) | 9 | |
Macrophage migration inhibitory factor | Homo sapiens (human) | 2.2 | |
Nitric oxide synthase, inducible | Mus musculus (house mouse) | 0.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Go, ML; Zhang, W | 1 |
1 other study(ies) available for isoindigotin and sulforaphane
Article | Year |
---|---|
Functionalized 3-benzylidene-indolin-2-ones: inducers of NAD(P)H-quinone oxidoreductase 1 (NQO1) with antiproliferative activity.
Topics: Animals; Antineoplastic Agents; Benzylidene Compounds; Cell Line, Tumor; Crystallography, X-Ray; Humans; Indoles; Mice; Molecular Conformation; NAD; NAD(P)H Dehydrogenase (Quinone); Up-Regulation | 2009 |